Clinical Research
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 7, 2006; 12(29): 4706-4709
Published online Aug 7, 2006. doi: 10.3748/wjg.v12.i29.4706
Table 1 Primers sequences of p53 gene exons 5-8
PrimersSequences
SenseAnti-sense
Exon 55′-TGT TCA CTT GTG CCC TGA CT-3′5′-CAG CCC TGT CGT CTC TCC AG-3′
Exon 65′-ACA GGG CTG GTT GCC CAG GGT-3′5′-CTC CCAGAG ACC CCA GTT GC-3′
Exon 75′-GGT CTC CCC AAG GCG CAC TGG-3′5′-AGG CTG GGG GCA CAG CAG GCC-3′
Exon 85′-ATT TCC TTA CTG CCT CTT GC-3′5′-AAG TGA ATC TGA GGC ATA AC-3
Table 2 Correlation of mutation status of p53 gene and P53 protein expression with pathologic parameters in cholangiocarcinoma
Pathologiccharacternp53 gene mutation
P53 protein expression
Positive (n, %)P vaulePositive (n, %)P vaule
Pathologic type
Tubular1811 (61.1)10 (55.6)
carcinoma
Papillary96 (66.7)5 ( 55.6)
carcinoma
Mucoid42 (50.0)2 (50.0)
carcinoma
Non-differentiated53 (60.0)> 0.052 (40.0)> 0.05
carcinoma
Differentiation
Well -Moderate2513 (52.0)9 (36.0)
Poor119 (81.8)> 0.0510 (90.9)< 0.05a
Invasion
T1167 (43.8)2 (12.5)
T2108 (80.0)8 (80.0)
T3107 (70.0)> 0.059 (90.0)< 0.05c
Lymph node metastasis
N032 (66.7)0 (0)
N13320 (60.6)> 0.0519 (57.5)> 0.05